All persons or entities that purchased or otherwise acquired the common stock of Recro Pharma, Inc. (“Recro” or the “Company”) from July 17, 2017 through May 23, 2018, inclusive.
Disbursed
July 16, 2017 - August 21, 2018
October 26, 2022
October 05, 2022
Strategic Claims Services
Recro Securities Litigationc/o Strategic Claims ServicesP.O. Box 230600 North Jackson Street – Suite 205Media, PA 19063
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.